Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4456 AL 4470

Homogenous Cell Transplantation Trials in Parkinson's Disease: A Systematic Review and Meta-Analysis

Reinisch N, Mancini A, Elsherbini A, Yuen J, Lozano A.

Mov Disord Clin Pract. 2026 May 3. doi: 10.1002/mdc3.70647. Online ahead of print.

Early Deep Brain Stimulation for Parkinson's Disease: A Systematic Review and Meta-Analysis

Araya JP, Zhu H, Anderson W, Merenzon M, Castillo CF, Escalante PA, Gutierrez RL.

Mov Disord Clin Pract. 2026 Oct;13(10):2341-2352. doi: 10.1002/mdc3.70666. Epub 2026 May 1.

Best practice guidelines for the diagnosis, evaluation, and management of cognitive disorders in Parkinson's disease

Pourzinal D, Brooks D, Sriram D, Mccann E, King JM, Pachana NA, Shrubsole K, Wood B, Lehn A, Marsh R, Liddle J, Mitchell LK, O'Sullivan JD, Tan ECK, Page N, Lobo EH, Verreynne ML, Lenzen S, Dissanayaka N.

Age Ageing. 2026 Mar 16;55(3):afag063. doi: 10.1093/ageing/afag063.

Neural correlates of emotional prosody in Parkinson's disease: A systematic review

Luciano SM, Panico F, De Biase R, Catalano L, Sagliano L, Trojano L.

Cogn Affect Behav Neurosci. 2026 Jan 8. doi: 10.3758/s13415-025-01379-w. Online ahead of print.

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease

Toffoli M, Menozzi E, Cullen M, Chowdhury K, Ahmed S, Freemantle N, Duffen J, Wyse RK, Stott SRW, Matthews H, Dexter D, Ikeji F, Moss J, Watts P, Foltynie T, Kieburtz K, Rascol O, Poewe W, Schapira AHV.

J Neurol. 2026 Feb 18;273(2):151. doi: 10.1007/s00415-026-13683-7.

Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centers

Geroin C, Ercoli T, Marcuzzo E, Sandri A, Camozzi S, Maddaloni D, Romito LM, Eleopra R, Tesolin L, Pellegrin S, Nicoletti A, Mostile G, Magliozzi A, Pilotto A, Modugno N, Olivola E, Demartini B, Nisticò V, Erro R, Cuoco S, Tessitore A, De Micco R, Ceravolo R, Del Prete E, Dallocchio C, Arbasino C, Esposito M, Assunta T, Bono F, Pascarella A, Petracca M, Zinzi P, Fabbrini G, Ferrazzano G, Bonanni L, Varanese S, Albanese A, Polverino P, Baglioni V, Defazio G, Zibetti M, Manganotti P, Solla P, Calandra-Buonaura G, Pisani A, Tinazzi M.

J Neurol. 2026 Mar 22;273(4):223. doi: 10.1007/s00415-026-13761-w.

Efficacy and safety of IPX203 in Parkinson's patients: a systematic review and meta-analysis

Alnajjar AZ, AbuZarifa M, Zakout KA, Alemour Y, Abouelmagd ME, Alshawamreh S, Aldirawi T, Meshref M.

Neurol Sci. 2026 Jan 22;47(2):187. doi: 10.1007/s10072-025-08692-9.

Untargeted serum metabolomics and air pollution in Parkinson's disease

Kwon D, Pual KC, Lin Y, Thordarson D, Wu J, Su J, Jones DP, Bronstein JM, Ritz B.

Res Sq [Preprint]. 2026 Mar 2:rs.3.rs-8857902. doi: 10.21203/rs.3.rs-8857902/v1.

Genetic Landscape of Monogenic Parkinson's Disease in the African Population-A Systematic Review

Banjaw Z, Assefa Z, Bogaert E, Crosiers D, Santens P, Dermaut B.

Mov Disord. 2026 Apr 9. doi: 10.1002/mds.70302. Online ahead of print.

Paraquat-induced rodent models of Parkinson's disease: A PRISMA-compliant systematic review and meta-analysis

Swain CC, Prevoznik S, Kalbus JA, Pokharel D, Beligala D, Jain P, Rami Reddy MVSR, Popovich C, Russell J, Subramanian T.

Neurotoxicology. 2026 Mar 21;114:103433. doi: 10.1016/j.neuro.2026.103433. Online ahead of print.

Enhancing Adherence to Home-Based Expiratory Muscle Strength Training in Parkinson Disease: Randomized Controlled Trial of an mHealth Intervention

Srp M, Hoskovcova M, Lagnerova R, Dvorakova K, Kliment R, Muzik J, Krupicka R, Gal O, Ruzicka E.

J Med Internet Res. 2026 Mar 11;28:e78022. doi: 10.2196/78022.

Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation

Leong IL, Ng TH, Sen K, Burchill E, Costello H, Badenoch JB, Coebergh J, McCutcheon RA, Nair A, Browning M, Huys QJM, Lewis G, Lees A, David AS, Rogers JP.

Brain. 2026 Jan 8;149(1):18-36. doi: 10.1093/brain/awaf335.

Enteral Nutrition in Idiopathic Parkinson's Disease and Atypical Parkinsonism: A Systematic Review

Lonergan B, Ciocca M, Schrag A, Tai Y.

Mov Disord Clin Pract. 2026 May 1. doi: 10.1002/mdc3.70653. Online ahead of print.

A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease

Tosefsky K, Lam JS, Wang YN, Keymanesh S, Kuan AJ, Metcalfe-Roach A, Cirstea MS, Sacheli MA, Brett Finlay B, Cohen TR, Appel-Cresswell S.

J Parkinsons Dis. 2026 Mar;16(2):332-350. doi: 10.1177/1877718X261418986. Epub 2026 Feb 4.

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and brain health: a systematic review

Batarseh N, Abdulla FA.

Nutr Neurosci. 2026 Jan 11:1-26. doi: 10.1080/1028415X.2025.2610643. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias